Article citationsMore>>
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P.C., Deutz, N.E.P., Erickson, N., et al. (2017) ESPEN Expert Group Recommendations for Action against Cancer-Related Malnutrition. Clinical Nutrition, 36, 1187-1196.
https://doi.org/10.1016/j.clnu.2017.06.017
has been cited by the following article:
-
TITLE:
Managing Cachexia and Improving Quality of Life in Cancer Patients Using Novel Nutritional Supplements: A PAN India Study
AUTHORS:
Snany Surendran, Radha Devi, Raktim Chattopadhyay, Anubhab Mukherjee, Shrikant Charde
KEYWORDS:
Cancer, Cachexia, Nutritional Intervention, Quality of Life
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.13 No.2,
February
22,
2022
ABSTRACT: Cancer patients develop cachexia due to systemic inflammation, negative protein and energy balance. Esperer Onco Nutrition (EON) has come up with
innovative nutritional supplements (EON Therapy) that help patients take the rigours of cancer therapy thereby improving
prognosis and Quality of Life (QoL).
This Post-marketing surveillance study was undertaken on 38 volunteers
to assess the impact of EON therapy on cachexia and QoL of patients undergoing
curative treatment. Body weight and biochemical parameters of the volunteers
were recorded at each visit. Volunteers were assessed using ECOG Scale and
Malnutrition Screening Tool (MST) to assess impact of nutritional supplements
on QoL. Weight loss was observed in most of the patients for first two visits
but the patients gained weight over subsequent visits and average weight at end
of the study was higher than initial weight. At the end of study 22 of 38
volunteers gained weight and 7 volunteers maintained initial weight. The
biochemical parameters either showed improvement or remained same. The QoL
analysis indicated a marked improvement in physical wellness and nutritional
status and no adverse effects were reported. In conclusion, the study
underlines importance of research based on nutritional supplements
for cancer patients for better disease management and prognosis.